DNA FY 2022 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$478M+52.2% YoY

Gross Profit

$273M57.3% margin

Operating Income

-$2.2B-462.4% margin

Net Income

-$2.1B-440.6% margin

EPS (Diluted)

$-50.20

Cash Flow

Operating Cash Flow

-$252M

Free Cash Flow

-$304M

Stock-Based Comp.

$1.9B

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$803M

Stockholders' Equity

$1.7B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$478M	$314M	+52.2%
Gross Profit	$273M	$184M	+48.5%
Operating Income	-$2.2B	-$1.8B	-20.8%
Net Income	-$2.1B	-$1.8B	-15.0%